Navigation Links
Increased Heart Attack Risk From Celebrex,Vioxx

CELEBREX (celecoxib capsules) is used for relief of the pain and inflammation of osteoarthritis and adult rheumatoid arthritis. By effectively reducing the pain, inflammation and stiffness of arthritis, celebrex can help you through the day with activities like standing, walking or climbing stairs, and through the night while sitting or lying in bed.

Since their introduction in 1999, the drugs, which are known technically as COX-2 inhibitors, have been among // America's best-selling prescription pharmaceuticals. One of them, Celecoxib, sold as Celebrex, was the sixth leading prescription drug used by 14 million people last year. The other COX-2 inhibitor is Rofecoxib, sold as Vioxx.

The drugs are popular because they provide the same pain- killing effects as aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, but with less chance of causing ulcers and intestinal bleeding.

Aspirin inhibits two closely related cyclooxygenase enzymes, COX-1 and COX-2. These new drugs specifically inhibit only the COX-2 (which is involved in pain and inflammation) while not affecting the first (which is involved in protecting lining of the stomach).

Celebrex, was recently approved by the Food and Drug Administration, FDA. The popular pain-killers Celebrex and Vioxx may slightly increase a person's risk of having a heart attack, according to an analysis of clinical studies of these 'super aspirin' drugs.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Allergy Risk Increased by Kerosene Use
3. Fewer teeth & Increased Ischemic Stroke risk
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
6. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
7. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
8. Diabetics Found To Be At An Increased Risk Of Developing Cancer
9. Increased Risk For Venous Thrombosis In Cancer Patients
10. Increased risk of common infections in patients suffering from diabetes
11. Infertility Associated With Increased Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & Associates’ ... years of experience in leading technology and human resources operations for health care, ... Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , Innovative Leaders ...
(Date:5/26/2016)... Farmington, CT; Scottsdale, AZ (PRWEB) , ... ... ... Leading insights consultancy, Actûrus , is happy to announce the launch ... linear thinking of the funnel model to reflect the dynamic landscape of ...
(Date:5/26/2016)... Madeira Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... island connected to the mainland by a single drawbridge, citizens formed an organization, Madeira ... increase already congested traffic and change the small town center to a high rise ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic ... host their second pop-up shop for three consecutive weekends. The pop-up shop is ... Santa Barbara community, a community full of women who appreciate the most premium ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food ... androgenetic alopecia in both men and women. To date, the company is the first ... clearance for any adult who suffers with androgenetic alopecia. , “This new level ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice ... officer, today. In his new role, Marziani will lead the company,s business development and ... to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology: